University Of Michigan Rogel Cancer Center

This study tested whether adding a pill called rucaparib to an existing immunotherapy (pembrolizumab) could help control stage IV non-squamous lung cancer for longer after initial chemotherapy. It aimed to see if this two-drug maintenance therapy was safe and could delay cancer p…

This study tested whether adding an experimental drug called CPI-613 to standard chemotherapy could better control advanced bile duct cancer. It involved 75 adults with cancer that couldn't be removed by surgery and who hadn't had prior treatment for advanced disease. The trial w…

This study tested whether fezolinetant could reduce hot flashes and night sweats in breast cancer patients taking hormone-blocking therapy. These side effects are common and bothersome for patients on these cancer-preventing medications. The trial compared the drug against a plac…